OVID - Ovid Therapeutics GAAP EPS of -$0.38 misses by $0.22 March, 15 2022 09:02 AM Ovid Therapeutics Inc. Ovid Therapeutics press release (NASDAQ:OVID): Q4 GAAP EPS of -$0.38 misses by $0.22. Cash and cash equivalents as of December 31, 2021 was $187.8M. For further details see: Ovid Therapeutics GAAP EPS of -$0.38 misses by $0.22